Investigating long-term effects of COVID-19.
OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository Core
This study is looking at the long-term health effects that people who have recovered from COVID-19 might experience, and it's for anyone who has had the virus and wants to help us understand how it affects health over time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10523260 on NIH RePORTER |
What this research studies
This research focuses on understanding the long-term health effects experienced by individuals who have recovered from COVID-19, known as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). It involves collecting and analyzing data from patients, as well as creating a biorepository to store biological samples for future studies. Patients will be monitored for various symptoms and health outcomes over time, helping to identify patterns and potential treatments for those suffering from lingering effects of the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have previously tested positive for COVID-19 and are experiencing ongoing health issues.
Not a fit: Patients who have not contracted COVID-19 or those without any post-viral symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of long-term COVID-19 symptoms, enhancing patient care and treatment options.
How similar studies have performed: Other research has shown promise in understanding post-viral syndromes, but this initiative aims to specifically address the unique challenges posed by COVID-19, making it a critical and timely investigation.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Katz, Stuart D — New York University School of Medicine
- Study coordinator: Katz, Stuart D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.